Bakhu Holdings, Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2020
June 12, 2020 at 08:31 pm
Share
Bakhu Holdings, Corp. announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced operating loss was USD 606,835 compared to USD 10.510 million a year ago. Net loss was USD 613,010 compared to USD 10.510 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.04 a year ago. For the nine months, operating loss was USD 709,580 compared to USD 10.632 million a year ago. Net loss was USD 721,223 compared to USD 10.632 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.08 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
